Trial intelligence / Profile preview

Effects of Bronchodilators on Dyspnea and Exercise in Mild COPD

NCT00202176Phase 4Completed

Sponsor
Queen's University
Start
Jul 2005
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ipratropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by Queen's University. Started Jul 2005; status: completed.

02

Drugs

ipratropium bromide
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00202176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00202176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call